Seastar Medical Hldg Corp (ICU)

$0.36 +0.02 (5.59%)
Market Cap 12.26M
Revenue (ttm) 140,000.00
Net Income (ttm) -24.83M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -17,735.71%
Debt to Equity Ratio 0.00
Volume 1,338,800
Avg Vol 2,881,236
Day's Range N/A - N/A
Shares Out 36.05M
Stochastic %K 100%
Beta -1.03
Analysts Strong Sell
Price Target $1.00

Company Profile

SeaStar Medical Holding Corporation, a commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI)...

Industry: Biotechnology
Sector: Healthcare
Phone: 844 427 8100
Address:
3513 Brighton Boulevard, Suite 410, Denver, United States
SparkyReturns
SparkyReturns Dec. 5 at 4:22 AM
$ICU That presentation was amazing! CRS study only needs 20 patients and then they can apply for HDE, new revenue stream! FDA will likely fast track approval like they've been doing for everything else. And those participating hospitals will immediately order a bunch! 10 Pediatric hospitals and growing. Only 18 more pediatric to go until SAVE registry requirement drops away. 150 adults enrolled in AKI! Insane opportunity of a lifetime here to invest at .35 !
0 · Reply
mchansen7
mchansen7 Dec. 5 at 4:07 AM
$ICU I just can’t believe that this is a $12M cap company. This product would transform the way we treat septic shock with AKI, which isn’t an uncommon problem in the ICU. I’m not sure why investors haven’t made this a private company given the importance of this treatment. Typically these types of company’s get private funding and go on to make multi Billions. Am I missing something here? Who cares about a reverse split coming up. If you have the ability to get some shares, this is a long haul investment!
2 · Reply
richard52
richard52 Dec. 5 at 3:47 AM
$ICU Good Noble presentation…. https://www.youtube.com/watch?v=XtBetZ3w-0A
2 · Reply
mchansen7
mchansen7 Dec. 5 at 3:18 AM
$ICU Does anyone have the discount code to register for Noblecon21? It’s $399 otherwise.
0 · Reply
josh77
josh77 Dec. 5 at 2:35 AM
$ICU need some good news!
1 · Reply
BULLISH1975
BULLISH1975 Dec. 5 at 1:18 AM
$ICU the delay is probably the people that did the conference. They have all the recording! i assume they get their shit together by tomorrow🙏
2 · Reply
Aznwactrackstar
Aznwactrackstar Dec. 4 at 11:47 PM
$ICU what a close. What an AH!
0 · Reply
BULLISH1975
BULLISH1975 Dec. 4 at 11:27 PM
$ICU has anyone been able to hear conference from Yesterday????? Dr Chung. please wake Eric up!!
2 · Reply
local42r
local42r Dec. 4 at 10:47 PM
$ICU 15 minutes ago
3 · Reply
MCDunefield
MCDunefield Dec. 4 at 9:36 PM
$ICU anyone been able to open the call yet? Link keeps directing me to the paid registration page
4 · Reply
Latest News on ICU
SeaStar Medical Announces FDA Approval of Reduction in Mandatory Enrollment for SAVE Surveillance Registry Evaluating QUELIMMUNE™ Safety for Pediatric AKI

Dec 2, 2025, 8:27 AM EST - 2 days ago

SeaStar Medical Announces FDA Approval of Reduction in Mandatory Enrollment for SAVE Surveillance Registry Evaluating QUELIMMUNE™ Safety for Pediatric AKI

SeaStar Medical to Present at Upcoming NobleCon21 Investor Conference

Nov 20, 2025, 9:52 AM EST - 14 days ago

SeaStar Medical to Present at Upcoming NobleCon21 Investor Conference

SeaStar Medical Announces Appointment of Michael Messinger as CFO

Nov 17, 2025, 8:43 AM EST - 17 days ago

SeaStar Medical Announces Appointment of Michael Messinger as CFO

SeaStar Medical Reports Third Quarter 2025 Financial Results and Provides Business Updates

Nov 13, 2025, 4:05 PM EST - 21 days ago

SeaStar Medical Reports Third Quarter 2025 Financial Results and Provides Business Updates

SeaStar Medical to Report Third Quarter Financial Results on November 13, 2025

Nov 5, 2025, 10:03 AM EST - 4 weeks ago

SeaStar Medical to Report Third Quarter Financial Results on November 13, 2025

SeaStar Medical Reports Positive Early Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) at the 5th International Symposium on Acute Kidney Injury in Children

Sep 29, 2025, 8:36 AM EDT - 2 months ago

SeaStar Medical Reports Positive Early Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) at the 5th International Symposium on Acute Kidney Injury in Children

SeaStar Medical Reports DSMB Recommendation to Continue the NEUTRALIZE-AKI Pivotal Trial in Adult Acute Kidney Injury

Sep 24, 2025, 4:22 PM EDT - 2 months ago

SeaStar Medical Reports DSMB Recommendation to Continue the NEUTRALIZE-AKI Pivotal Trial in Adult Acute Kidney Injury

SeaStar Medical to Present Early SAVE Registry Data of QUELIMMUNE in Pediatric Acute Kidney Injury at the 5th International Symposium on Acute Kidney Injury in Children

Sep 23, 2025, 8:23 AM EDT - 2 months ago

SeaStar Medical to Present Early SAVE Registry Data of QUELIMMUNE in Pediatric Acute Kidney Injury at the 5th International Symposium on Acute Kidney Injury in Children

SeaStar Medical to Participate in the HC Wainwright 27th Annual Global Investment Conference

Sep 4, 2025, 6:13 PM EDT - 3 months ago

SeaStar Medical to Participate in the HC Wainwright 27th Annual Global Investment Conference

SeaStar Medical Announces Newly Published QUELIMMUNE Health Economic Study Projecting Significantly Reduced Health Care Costs in the Treatment of Pediatric AKI due to Estimated Shorter Hospital Stays and Increased Survival

Sep 2, 2025, 8:22 AM EDT - 3 months ago

SeaStar Medical Announces Newly Published QUELIMMUNE Health Economic Study Projecting Significantly Reduced Health Care Costs in the Treatment of Pediatric AKI due to Estimated Shorter Hospital Stays and Increased Survival

SeaStar Medical Reports Second Quarter 2025 Financial Results and Provides Business Updates

Aug 13, 2025, 4:05 PM EDT - 4 months ago

SeaStar Medical Reports Second Quarter 2025 Financial Results and Provides Business Updates

SeaStar Medical to Report Second Quarter Financial Results on August 13, 2025

Aug 7, 2025, 10:00 AM EDT - 4 months ago

SeaStar Medical to Report Second Quarter Financial Results on August 13, 2025

SeaStar Medical Reaches New Enrollment Milestone in NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury (AKI)

Aug 6, 2025, 8:33 AM EDT - 4 months ago

SeaStar Medical Reaches New Enrollment Milestone in NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury (AKI)

SeaStar Medical Announces $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Jul 31, 2025, 3:01 PM EDT - 4 months ago

SeaStar Medical Announces $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

SeaStar Medical Reports Positive Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) from the First 20 SAVE Surveillance Registry Patients

Jul 22, 2025, 8:20 AM EDT - 4 months ago

SeaStar Medical Reports Positive Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) from the First 20 SAVE Surveillance Registry Patients

SeaStar Medical Grows Customer Base and Expands QUELIMMUNE Surveillance Registry

Jul 16, 2025, 8:45 AM EDT - 5 months ago

SeaStar Medical Grows Customer Base and Expands QUELIMMUNE Surveillance Registry

SeaStar Medical Announces $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Jul 10, 2025, 3:29 PM EDT - 5 months ago

SeaStar Medical Announces $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

SeaStar Medical Expands QUELIMMUNE Adoption for Critically Ill Pediatric Patients with Acute Kidney Injury (AKI)

Jul 8, 2025, 8:05 AM EDT - 5 months ago

SeaStar Medical Expands QUELIMMUNE Adoption for Critically Ill Pediatric Patients with Acute Kidney Injury (AKI)

SeaStar Medical Announces Positive Nasdaq Listing Determination

Jul 2, 2025, 4:25 PM EDT - 5 months ago

SeaStar Medical Announces Positive Nasdaq Listing Determination

SeaStar Medical Reports Update on Nasdaq Listing Status

Jun 25, 2025, 8:05 AM EDT - 5 months ago

SeaStar Medical Reports Update on Nasdaq Listing Status

SeaStar Medical Announces Two Feature Stories on QUELIMMUNE Adoption and Patient Testimonial of Life-Saving Therapy

Jun 24, 2025, 9:05 AM EDT - 5 months ago

SeaStar Medical Announces Two Feature Stories on QUELIMMUNE Adoption and Patient Testimonial of Life-Saving Therapy

SeaStar Medical Announces Pricing of Up to $8 Million Public Offering

Jun 20, 2025, 12:10 PM EDT - 5 months ago

SeaStar Medical Announces Pricing of Up to $8 Million Public Offering

AREVA Institute and SeaStar Medical Announce DoD Award of Prestigious Military Grant to AREVA Institute to Evaluate SeaStar Medical's SCD Therapy to Advance Breakthrough Burn and Sepsis Research

Jun 11, 2025, 8:25 AM EDT - 6 months ago

AREVA Institute and SeaStar Medical Announce DoD Award of Prestigious Military Grant to AREVA Institute to Evaluate SeaStar Medical's SCD Therapy to Advance Breakthrough Burn and Sepsis Research

SeaStar Medical Announces CMS Coverage for Medicare and Medicaid Eligible Patients with Cardiorenal Syndrome Awaiting LVAD in Investigational Trial of SCD Therapy

May 28, 2025, 8:05 AM EDT - 6 months ago

SeaStar Medical Announces CMS Coverage for Medicare and Medicaid Eligible Patients with Cardiorenal Syndrome Awaiting LVAD in Investigational Trial of SCD Therapy

SeaStar Medical Holding Corporation (ICU) Q1 2025 Earnings Call Transcript

May 14, 2025, 9:49 PM EDT - 7 months ago

SeaStar Medical Holding Corporation (ICU) Q1 2025 Earnings Call Transcript

SeaStar Medical Reports First Quarter 2025 Financial Results and Provides Business Updates

May 14, 2025, 4:05 PM EDT - 7 months ago

SeaStar Medical Reports First Quarter 2025 Financial Results and Provides Business Updates

SeaStar Medical Reaches Interim Enrollment Target for NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury

May 13, 2025, 8:05 AM EDT - 7 months ago

SeaStar Medical Reaches Interim Enrollment Target for NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury

SeaStar Medical to Report First Quarter Financial Results on May 14, 2025

May 7, 2025, 10:00 AM EDT - 7 months ago

SeaStar Medical to Report First Quarter Financial Results on May 14, 2025

SeaStar Medical Announces CEO Interview on Benzinga All Access to Occur Today at Approximately 10:50 am Eastern Time

Apr 30, 2025, 8:05 AM EDT - 7 months ago

SeaStar Medical Announces CEO Interview on Benzinga All Access to Occur Today at Approximately 10:50 am Eastern Time

FDA Grants SeaStar Medical Two New Breakthrough Device Designations for SCD Therapy to Treat Systemic Inflammatory Response in Adult and Pediatric Patients Undergoing Cardiac Surgery

Apr 8, 2025, 8:05 AM EDT - 8 months ago

FDA Grants SeaStar Medical Two New Breakthrough Device Designations for SCD Therapy to Treat Systemic Inflammatory Response in Adult and Pediatric Patients Undergoing Cardiac Surgery

SeaStar Medical Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

Mar 27, 2025, 4:05 PM EDT - 9 months ago

SeaStar Medical Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

SeaStar Medical to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025

Mar 24, 2025, 5:30 PM EDT - 9 months ago

SeaStar Medical to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025

NKF Honors SeaStar Medical, with 2025 Corporate Innovator Award

Mar 18, 2025, 8:45 AM EDT - 9 months ago

NKF Honors SeaStar Medical, with 2025 Corporate Innovator Award

SeaStar Medical Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market

Feb 3, 2025, 4:05 PM EST - 10 months ago

SeaStar Medical Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market

SeaStar Medical Activates 15th Site for its Adult Acute Kidney Injury Pivotal Trial

Jan 22, 2025, 7:30 AM EST - 11 months ago

SeaStar Medical Activates 15th Site for its Adult Acute Kidney Injury Pivotal Trial

FDA Approves Feasibility Study with SeaStar Medical's Selective Cytopheretic Device in Adults with Cardiorenal Syndrome

Jan 13, 2025, 8:30 AM EST - 11 months ago

FDA Approves Feasibility Study with SeaStar Medical's Selective Cytopheretic Device in Adults with Cardiorenal Syndrome

SeaStar Medical Begins Shipping QUELIMMUNE to a Fourth Hospital Customer

Jan 8, 2025, 8:30 AM EST - 11 months ago

SeaStar Medical Begins Shipping QUELIMMUNE to a Fourth Hospital Customer

SeaStar Medical Activates 14th Hospital for its Adult AKI Pivotal Trial

Dec 23, 2024, 7:00 AM EST - 1 year ago

SeaStar Medical Activates 14th Hospital for its Adult AKI Pivotal Trial

SeaStar Medical Projects Multibillion-Dollar Market Potential for its Selective Cytopheretic Device in Initial Target Indications

Dec 11, 2024, 6:30 AM EST - 1 year ago

SeaStar Medical Projects Multibillion-Dollar Market Potential for its Selective Cytopheretic Device in Initial Target Indications

SeaStar Medical to Hold Business Update Conference Call on December 11, 2024

Dec 4, 2024, 8:30 AM EST - 1 year ago

SeaStar Medical to Hold Business Update Conference Call on December 11, 2024

SeaStar Medical to Present at Noble Capital Markets' NobleCon20 on December 4, 2024

Nov 26, 2024, 8:00 AM EST - 1 year ago

SeaStar Medical to Present at Noble Capital Markets' NobleCon20 on December 4, 2024

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Support SeaStar Medical's Proposals to Ratify the Issuance of Shares and to Reduce the Number of Authorized Shares

Nov 22, 2024, 8:30 AM EST - 1 year ago

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Support SeaStar Medical's Proposals to Ratify the Issuance of Shares and to Reduce the Number of Authorized Shares

SeaStar Medical Reaches Milestone of 100th QUELIMMUNE Commercial Device as Shipments Begin to its Third Hospital Customer

Nov 15, 2024, 8:30 AM EST - 1 year ago

SeaStar Medical Reaches Milestone of 100th QUELIMMUNE Commercial Device as Shipments Begin to its Third Hospital Customer

SeaStar Medical Reports Third Quarter 2024 Financial Results and Provides a Business Update

Nov 13, 2024, 5:05 PM EST - 1 year ago

SeaStar Medical Reports Third Quarter 2024 Financial Results and Provides a Business Update

Record Monthly Enrollment Achieved in SeaStar Medical's Pivotal Adult AKI Trial

Nov 1, 2024, 8:30 AM EDT - 1 year ago

Record Monthly Enrollment Achieved in SeaStar Medical's Pivotal Adult AKI Trial

SeaStar Medical Adds Second Hospital Customer for QUELIMMUNE

Oct 31, 2024, 8:30 AM EDT - 1 year ago

SeaStar Medical Adds Second Hospital Customer for QUELIMMUNE

Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical's QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024 - Update

Oct 25, 2024, 11:32 AM EDT - 1 year ago

Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical's QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024 - Update

Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical's QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024

Oct 25, 2024, 8:30 AM EDT - 1 year ago

Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical's QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024

SeaStar Medical to Distribute QUELIMMUNE Directly to Hospital Customers

Oct 22, 2024, 8:30 AM EDT - 1 year ago

SeaStar Medical to Distribute QUELIMMUNE Directly to Hospital Customers

SeaStar Medical Announces that Enrollment in its Adult Acute Kidney Injury Pivotal Trial Has Exceeded the Halfway Point Toward an Interim Analysis

Oct 18, 2024, 8:30 AM EDT - 1 year ago

SeaStar Medical Announces that Enrollment in its Adult Acute Kidney Injury Pivotal Trial Has Exceeded the Halfway Point Toward an Interim Analysis

SparkyReturns
SparkyReturns Dec. 5 at 4:22 AM
$ICU That presentation was amazing! CRS study only needs 20 patients and then they can apply for HDE, new revenue stream! FDA will likely fast track approval like they've been doing for everything else. And those participating hospitals will immediately order a bunch! 10 Pediatric hospitals and growing. Only 18 more pediatric to go until SAVE registry requirement drops away. 150 adults enrolled in AKI! Insane opportunity of a lifetime here to invest at .35 !
0 · Reply
mchansen7
mchansen7 Dec. 5 at 4:07 AM
$ICU I just can’t believe that this is a $12M cap company. This product would transform the way we treat septic shock with AKI, which isn’t an uncommon problem in the ICU. I’m not sure why investors haven’t made this a private company given the importance of this treatment. Typically these types of company’s get private funding and go on to make multi Billions. Am I missing something here? Who cares about a reverse split coming up. If you have the ability to get some shares, this is a long haul investment!
2 · Reply
richard52
richard52 Dec. 5 at 3:47 AM
$ICU Good Noble presentation…. https://www.youtube.com/watch?v=XtBetZ3w-0A
2 · Reply
mchansen7
mchansen7 Dec. 5 at 3:18 AM
$ICU Does anyone have the discount code to register for Noblecon21? It’s $399 otherwise.
0 · Reply
josh77
josh77 Dec. 5 at 2:35 AM
$ICU need some good news!
1 · Reply
BULLISH1975
BULLISH1975 Dec. 5 at 1:18 AM
$ICU the delay is probably the people that did the conference. They have all the recording! i assume they get their shit together by tomorrow🙏
2 · Reply
Aznwactrackstar
Aznwactrackstar Dec. 4 at 11:47 PM
$ICU what a close. What an AH!
0 · Reply
BULLISH1975
BULLISH1975 Dec. 4 at 11:27 PM
$ICU has anyone been able to hear conference from Yesterday????? Dr Chung. please wake Eric up!!
2 · Reply
local42r
local42r Dec. 4 at 10:47 PM
$ICU 15 minutes ago
3 · Reply
MCDunefield
MCDunefield Dec. 4 at 9:36 PM
$ICU anyone been able to open the call yet? Link keeps directing me to the paid registration page
4 · Reply
Unitypal
Unitypal Dec. 4 at 9:29 PM
$ICU !!!!!! ATM offering AH?
2 · Reply
mchansen7
mchansen7 Dec. 4 at 9:20 PM
$ICU Strong SP drop after hours with no sale volume, and just buying pressure???
1 · Reply
Nikki7220
Nikki7220 Dec. 4 at 9:14 PM
$ICU ***** IMHO, our SP will gradually moving UP and up and up for YEARS. Our SP is NO longer a threat from the crooks. Worst a few pennies down and up in dollar.
0 · Reply
AvengerTrader
AvengerTrader Dec. 4 at 8:47 PM
What is happening to ticker SNSE now?! Looks like they are going to SQUEEZE ticker SNSE up next .. SNSE is breaking out like crazy.. Are they pumping up SNSE for 300% !? Its insane what's going on in this market.. Looks like all eyes are going to SNSE now.. Watching: $ALT $IBRX $ICU $NVAX also
0 · Reply
BULLISH1975
BULLISH1975 Dec. 4 at 8:28 PM
$ICU if i was CEO or CFO I would say. given the save register news. we expect revenue to ramp up fast. we have sufficient cash for a few quarters ATM. we are going to try avoid further dilution. we will consider taking a 5 million loan mid 2026 if needed. we expect growing revenue to be sufficient to pay off interest for a few quarters till we cash flow positive…, I think SP would rally hard!! dyor
4 · Reply
YandH
YandH Dec. 4 at 8:09 PM
$ICU The move to Europe will be relatively swift. https://www.hma.eu/about-hma/recently-published.html
1 · Reply
mchansen7
mchansen7 Dec. 4 at 8:07 PM
$ICU SP has hit this .3519 ceiling 3 times already today. Looking great!
0 · Reply
BULLISH1975
BULLISH1975 Dec. 4 at 7:48 PM
$ICU Looking foward to 4pm to see if there was anything new in the conference from yesterday. accumulation
0 · Reply
SparkyReturns
SparkyReturns Dec. 4 at 7:37 PM
$ICU I'm trying folks. I've been buying way more than my minimum 200 shares/day. Fortunately I was able to take my CAPR gains over here. GL longs!
2 · Reply
babakbb
babakbb Dec. 4 at 7:19 PM
$ICU About to break above volume shelf and go for a nice run
1 · Reply
Nikki7220
Nikki7220 Dec. 4 at 7:16 PM
$ICU ***** VOTING = 100% will PASS! My YES vote alone = more than so many in here. Lets move on shall we. Try your best to bring down a few pennies and we will consume all of your shares. Then up up up for YEARS.
1 · Reply
2damoooooo
2damoooooo Dec. 4 at 7:01 PM
$ICU Dec. 18 voting for RS … 1 for 10 Anyone’s???
3 · Reply